Syneron Medical Ltd (ELOS) - Financial and Strategic SWOT Analysis Review
Syneron Medical Ltd (ELOS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Syneron Medical Ltd (Syneron) is an aesthetic medical device company. It designs, develops and markets aesthetic medical products. The company products target a range of non-invasive aesthetic medical procedures and address wide range of cosmetic and medical indications such as treatment of leg veins, acne treatment, wrinkle reduction, hair removal, skin rejuvenation of the skin’s appearance, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin, and a minimally invasive product for laser-assisted lipolysis. Syneron utilizes various technologies including its proprietary Electro-Optical Synergy (ELOS) technology to develop aesthetic medical products. It sells products through a network of distributors and subsidiaries located in the US, Canada, Israel, Spain, France, Germany, Italy, Portugal, the UK, China, Hong Kong, Japan and Australia. Syneron is headquartered in Yokneam Illit, Israel.
Syneron Medical Ltd Key Recent Developments
May 17,2017: Syneron Medical Reports First Quarter 2017 Revenue of $66.9 Million
Mar 01,2017: Syneron Candela Announces New Technology and Indications at the 2017 American Academy of Dermatology Annual Meeting
Feb 15,2017: Syneron Medical Reports Fourth Quarter 2016 Revenue of $82.9 Million and Full Year 2016 Revenue $298.1 Million
Jan 31,2017: Syneron Medical Strengthens Senior Management Team with Appointment of Chief Human Resources Officer
Nov 09,2016: Syneron Medical Reports Third Quarter 2016 Revenue of $71.5 Million
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Syneron Medical Ltd (Syneron) is an aesthetic medical device company. It designs, develops and markets aesthetic medical products. The company products target a range of non-invasive aesthetic medical procedures and address wide range of cosmetic and medical indications such as treatment of leg veins, acne treatment, wrinkle reduction, hair removal, skin rejuvenation of the skin’s appearance, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin, and a minimally invasive product for laser-assisted lipolysis. Syneron utilizes various technologies including its proprietary Electro-Optical Synergy (ELOS) technology to develop aesthetic medical products. It sells products through a network of distributors and subsidiaries located in the US, Canada, Israel, Spain, France, Germany, Italy, Portugal, the UK, China, Hong Kong, Japan and Australia. Syneron is headquartered in Yokneam Illit, Israel.
Syneron Medical Ltd Key Recent Developments
May 17,2017: Syneron Medical Reports First Quarter 2017 Revenue of $66.9 Million
Mar 01,2017: Syneron Candela Announces New Technology and Indications at the 2017 American Academy of Dermatology Annual Meeting
Feb 15,2017: Syneron Medical Reports Fourth Quarter 2016 Revenue of $82.9 Million and Full Year 2016 Revenue $298.1 Million
Jan 31,2017: Syneron Medical Strengthens Senior Management Team with Appointment of Chief Human Resources Officer
Nov 09,2016: Syneron Medical Reports Third Quarter 2016 Revenue of $71.5 Million
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY
Syneron Medical Ltd - Key Facts
Syneron Medical Ltd - Key Employees
Syneron Medical Ltd - Key Employee Biographies
Syneron Medical Ltd - Major Products and Services
Syneron Medical Ltd - History
Syneron Medical Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
SECTION 2 – COMPANY ANALYSIS
Syneron Medical Ltd - Business Description
Syneron Medical Ltd - Corporate Strategy
Syneron Medical Ltd - SWOT Analysis
SWOT Analysis - Overview
Syneron Medical Ltd - Strengths
Syneron Medical Ltd - Weaknesses
Syneron Medical Ltd - Opportunities
Syneron Medical Ltd - Threats
Syneron Medical Ltd - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Syneron Medical Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017
Syneron Medical Ltd, Medical Equipment, Deals By Type, 2011 to YTD 2017
Syneron Medical Ltd, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
May 17, 2017: Syneron Medical Reports First Quarter 2017 Revenue of $66.9 Million
Feb 15, 2017: Syneron Medical Reports Fourth Quarter 2016 Revenue of $82.9 Million and Full Year 2016 Revenue $298.1 Million
Jan 31, 2017: Syneron Medical Strengthens Senior Management Team with Appointment of Chief Human Resources Officer
Nov 09, 2016: Syneron Medical Reports Third Quarter 2016 Revenue of $71.5 Million
Oct 17, 2016: Syneron Medical Strengthens Senior Management Team
Oct 17, 2016: Syneron Medical Announces Preliminary Third Quarter 2016 Revenue
Aug 04, 2016: Syneron Medical Reports Second Quarter 2016 Revenue of $75.0 Million and Non-GAAP EPS of $0.09
May 19, 2016: Syneron Medical Reports First Quarter 2016 Revenue of $68.7 Million
Mar 03, 2016: Syneron Candela to Introduce Ultra-Short PicoWay Laser at the 2016 American Academy of Dermatology Annual Meeting
Mar 03, 2016: Syneron Candela to Introduce SubQ Profound Applicator at the 2016 American Academy of Dermatology Annual Meeting
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
Syneron Medical Ltd - Key Facts
Syneron Medical Ltd - Key Employees
Syneron Medical Ltd - Key Employee Biographies
Syneron Medical Ltd - Major Products and Services
Syneron Medical Ltd - History
Syneron Medical Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
SECTION 2 – COMPANY ANALYSIS
Syneron Medical Ltd - Business Description
Syneron Medical Ltd - Corporate Strategy
Syneron Medical Ltd - SWOT Analysis
SWOT Analysis - Overview
Syneron Medical Ltd - Strengths
Syneron Medical Ltd - Weaknesses
Syneron Medical Ltd - Opportunities
Syneron Medical Ltd - Threats
Syneron Medical Ltd - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Syneron Medical Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017
Syneron Medical Ltd, Medical Equipment, Deals By Type, 2011 to YTD 2017
Syneron Medical Ltd, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
May 17, 2017: Syneron Medical Reports First Quarter 2017 Revenue of $66.9 Million
Feb 15, 2017: Syneron Medical Reports Fourth Quarter 2016 Revenue of $82.9 Million and Full Year 2016 Revenue $298.1 Million
Jan 31, 2017: Syneron Medical Strengthens Senior Management Team with Appointment of Chief Human Resources Officer
Nov 09, 2016: Syneron Medical Reports Third Quarter 2016 Revenue of $71.5 Million
Oct 17, 2016: Syneron Medical Strengthens Senior Management Team
Oct 17, 2016: Syneron Medical Announces Preliminary Third Quarter 2016 Revenue
Aug 04, 2016: Syneron Medical Reports Second Quarter 2016 Revenue of $75.0 Million and Non-GAAP EPS of $0.09
May 19, 2016: Syneron Medical Reports First Quarter 2016 Revenue of $68.7 Million
Mar 03, 2016: Syneron Candela to Introduce Ultra-Short PicoWay Laser at the 2016 American Academy of Dermatology Annual Meeting
Mar 03, 2016: Syneron Candela to Introduce SubQ Profound Applicator at the 2016 American Academy of Dermatology Annual Meeting
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Syneron Medical Ltd, Key Facts
Syneron Medical Ltd, Key Employees
Syneron Medical Ltd, Key Employee Biographies
Syneron Medical Ltd, Major Products and Services
Syneron Medical Ltd, History
Syneron Medical Ltd, Subsidiaries
Syneron Medical Ltd, Joint Venture
Syneron Medical Ltd, Key Competitors
Syneron Medical Ltd, Ratios based on current share price
Syneron Medical Ltd, Annual Ratios
Syneron Medical Ltd, Annual Ratios (Cont.1)
Syneron Medical Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017
Syneron Medical Ltd, Medical Equipment, Deals By Type, 2011 to YTD 2017
Syneron Medical Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Syneron Medical Ltd, Key Facts
Syneron Medical Ltd, Key Employees
Syneron Medical Ltd, Key Employee Biographies
Syneron Medical Ltd, Major Products and Services
Syneron Medical Ltd, History
Syneron Medical Ltd, Subsidiaries
Syneron Medical Ltd, Joint Venture
Syneron Medical Ltd, Key Competitors
Syneron Medical Ltd, Ratios based on current share price
Syneron Medical Ltd, Annual Ratios
Syneron Medical Ltd, Annual Ratios (Cont.1)
Syneron Medical Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017
Syneron Medical Ltd, Medical Equipment, Deals By Type, 2011 to YTD 2017
Syneron Medical Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
Syneron Medical Ltd, Performance Chart (2012 - 2016)
Syneron Medical Ltd, Ratio Charts
Syneron Medical Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017
Syneron Medical Ltd, Medical Equipment, Deals by Type, 2011 to YTD 2017
COMPANIES MENTIONED
Sciton Inc
Lutronic, Inc.
Lumenis Ltd
Cynosure Inc
Alma Lasers Ltd
Syneron Medical Ltd, Performance Chart (2012 - 2016)
Syneron Medical Ltd, Ratio Charts
Syneron Medical Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017
Syneron Medical Ltd, Medical Equipment, Deals by Type, 2011 to YTD 2017
COMPANIES MENTIONED
Sciton Inc
Lutronic, Inc.
Lumenis Ltd
Cynosure Inc
Alma Lasers Ltd